Real-world rates of FDA-approved targeted therapy and immunotherapy prescriptions for patients with metastatic colorectal cancer in the VA's National Precision Oncology Program (NPOP)
Publication
, Conference
Djotsa, AN; Winski, D; Nguyen, TH-A; Ahmed, S; Strickler, JH; Becker, DJ; Vashistha, V; Kelley, MJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Djotsa, A. N., Winski, D., Nguyen, T.-A., Ahmed, S., Strickler, J. H., Becker, D. J., … Kelley, M. J. (2023). Real-world rates of FDA-approved targeted therapy and immunotherapy prescriptions for patients with metastatic colorectal cancer in the VA's National Precision Oncology Program (NPOP). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Djotsa, Alice Nono, David Winski, Theresa Hoang-Anh Nguyen, Sara Ahmed, John H. Strickler, Daniel Jacob Becker, Vishal Vashistha, and Michael J. Kelley. “Real-world rates of FDA-approved targeted therapy and immunotherapy prescriptions for patients with metastatic colorectal cancer in the VA's National Precision Oncology Program (NPOP).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Djotsa AN, Winski D, Nguyen TH-A, Ahmed S, Strickler JH, Becker DJ, et al. Real-world rates of FDA-approved targeted therapy and immunotherapy prescriptions for patients with metastatic colorectal cancer in the VA's National Precision Oncology Program (NPOP). In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Djotsa, Alice Nono, et al. “Real-world rates of FDA-approved targeted therapy and immunotherapy prescriptions for patients with metastatic colorectal cancer in the VA's National Precision Oncology Program (NPOP).” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.
Djotsa AN, Winski D, Nguyen TH-A, Ahmed S, Strickler JH, Becker DJ, Vashistha V, Kelley MJ. Real-world rates of FDA-approved targeted therapy and immunotherapy prescriptions for patients with metastatic colorectal cancer in the VA's National Precision Oncology Program (NPOP). JOURNAL OF CLINICAL ONCOLOGY. 2023.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences